Lenalid contains Lenalidomide 25mg, a prescription medicine used to treat certain types of blood cancers, including multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL).
| Generic Name | Lenalidomide |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules in 1 Bottle |
| Prescribed For | Multiple myeloma |
| Availability | In Stock |
Lenakast (Lenalidomide 25 mg) is an oral immunomodulatory medicine used in the treatment of multiple myeloma and certain blood disorders. It helps slow cancer cell growth, supports immune response, and is commonly used as part of combination therapy under medical supervision.
| Generic Name | Lenalidomide |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Capsules in 1 Bottle |
| Prescribed For | Multiple myeloma |
| Availability | In Stock |
Ibrunat contains Ibrutinib 140mg, a targeted cancer therapy used to treat certain blood cancers such as Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL), and Waldenström’s Macroglobulinemia (WM).
| Generic Name | Ibrutinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules |
| Prescribed For | Blood Cancers |
| Availability | In Stock |
Imat contains Imatinib 400mg, a targeted chemotherapy medicine used to treat certain types of cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs).
| Generic Name | Imatinib |
| Manufacturer | Zydus Healthcare Limited |
| Packing | 120 Tablets |
| Prescribed For | Chronic Myeloid Leukemia and Gastrointestinal Stromal Tumors |
| Availability | In Stock |
Imatikast contains Imatinib 400mg, a targeted cancer therapy used to treat certain types of cancers such as Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and Gastrointestinal Stromal Tumors (GISTs).
| Generic Name | Imatinib |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 10 Tablets in 1 Strip |
| Prescribed For | Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Gastrointestinal Stromal Tumors |
| Availability | In Stock |
Invista contains Dasatinib 100mg, a targeted cancer medication used in the treatment of certain types of blood cancers, including Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) that are Philadelphia chromosome-positive.
| Generic Name | Dasatinib |
| Manufacturer | Dr Reddy’s Laboratories Ltd |
| Packing | 30 Tablets |
| Prescribed For | Chronic Myeloid Leukemia |
| Availability | In Stock |
Lenangio contains Lenalidomide 25mg, a medicine used to treat certain types of blood cancers such as multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL).
| Generic Name | Lenalidomide |
| Manufacturer | Dr Reddy’s Laboratories Ltd |
| Packing | 10 Capsules |
| Prescribed For | Multiple Myeloma, Myelodysplastic Syndrome and Mantle Cell Lymphoma |
| Availability | In Stock |
Leu Kinib contains Dasatinib 70mg, a targeted therapy used for treating certain types of blood cancers such as Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL).
| Generic Name | Dasatinib |
| Manufacturer | Sayre Therapeutics Pvt Ltd |
| Packing | 60 Tablets |
| Prescribed For | Blood Cancer |
| Availability | In Stock |
Nextki contains Dasatinib 100mg, a targeted cancer therapy used to treat certain blood cancers, specifically Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL).
| Generic Name | Dasatinib |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 30 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Availability | In Stock |
Nitib contains Ibrutinib 140mg, a targeted therapy used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström’s macroglobulinemia.
| Generic Name | Ibrutinib |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 30 Capsules |
| Prescribed For | Blood Cancer |
| Availability | In Stock |
Pomalid contains Pomalidomide 2mg, an immunomodulatory drug used in the treatment of multiple myeloma (a type of blood cancer), especially in patients who have not responded to other therapies such as lenalidomide and bortezomib.
| Generic Name | Pomalidomide |
| Manufacturer | Natco Pharma Ltd |
| Packing | 21 Capsules in 1 Bottle |
| Prescribed For | Multiple Myeloma |
| Availability | In Stock |
Relidomide 25 capsules contains Lenalidomide 25mg, an immunomodulatory medication primarily used in the treatment of certain blood cancers such as multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma.
| Generic Name | Lenalidomide 25mg |
| Manufacturer | Reliance Life Sciences |
| Packing | 21 Capsules |
| Prescribed For | Multiple Myeloma |
| Availability | In Stock |
Spnib 50mg/100mg contains dasatinib, a tyrosine kinase inhibitor used to treat certain types of blood cancers, specifically chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+).
| Generic Name | Dasatinib |
| Manufacturer | Zydus Cadila |
| Packing | 60 Tablets |
| Prescribed For | Blood Cancer |
| Availability | In Stock |
Sprycel 50mg contains Dasatinib, a targeted cancer therapy used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
| Generic Name | Dasatinib |
| Manufacturer | BMS India Pvt Ltd |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Availability | In Stock |
Daslemia 70 mg is an oral prescription medication that contains dasatinib, a targeted therapy classified as a tyrosine kinase inhibitor (TKI), and it is primarily used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) and Ph+ acute lymphoblastic leukemia (Ph+ ALL).
| Generic Name | Dasatinib |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Packing | 60 Tablets |
| Prescribed For | Blood Cancer |
| Availability | In Stock |
Dasatrue 70 mg tablet contains dasatinib and is used to treat certain types of blood cancer, especially chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It helps stop the growth of abnormal white blood cells.
| Generic Name | Dasatinib |
| Manufacturer | Cipla Ltd |
| Packing | 60 Tablets |
| Prescribed For | Blood Cancer |
| Availability | In Stock |
Dasashil 70mg is a prescription cancer medicine that contains Dasatinib, a tyrosine kinase inhibitor (TKI), and it is primarily used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
| Generic Name | Dasatinib |
| Manufacturer | Shilpa Medicare Ltd |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Availability | In Stock |
Dasapan 70mg is a prescription medicine that contains Dasatinib, a potent tyrosine kinase inhibitor (TKI) used in the treatment of specific blood cancers. It is primarily prescribed to patients with Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL).
| Generic Name | Dasatinib |
| Manufacturer | Mankind Pharma Ltd |
| Packing | 60 Tablets in 1 Bottle |
| Prescribed For | Blood Cancer |
| Availability | In Stock |
Dasamyl 100 mg contains dasatinib, and it is a targeted therapy medication used in the treatment of certain types of blood cancer, specifically Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
| Generic Name | Dasatinib |
| Manufacturer | Mylan Pharmaceuticals Pvt Ltd |
| Packing | 30 Tablets |
| Prescribed For | Blood Cancer |
| Availability | In Stock |
| Generic Name | Dasatinib |
| Manufacturer | AMPS Biotech Pvt Ltd |
| Packing | 60 Tablets |
| Prescribed For | Blood Cancer |
| Availability | In Stock |
| Generic Name | Dasatinib |
| Manufacturer | Aprazer Healthcare Pvt ltd |
| Packing | 60 Tablets |
| Prescribed For | Blood Cancer |
| Availability | In Stock |
